Lataa...
Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom
BACKGROUND: Overactive bladder (OAB) is highly prevalent and is associated with considerable morbidity and reduced health-related quality of life. β(3)-adrenergic receptor (β(3)-AR) stimulation is a novel alternative to antimuscarinic therapy for OAB. OBJECTIVE: The objective of this analysis was to...
Tallennettuna:
| Julkaisussa: | Clin Drug Investig |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4300413/ https://ncbi.nlm.nih.gov/pubmed/25491433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-014-0240-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|